Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis
Clinical trial NCT02930044 · COMPLETED
Trial details
- NCT number
- NCT02930044
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2021-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.